Tonix Pharmaceuticals (TNXP) stock plunged after the company carried out a 1-for-100 reverse stock split as it awaits approval for its ...

Research analysts at StockNews.com initiated coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a research note issued to investors on Monday. The brokerage set a “sell” ...

The reverse stock split will be effective for trading ... Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed ...

Tonix Pharmaceuticals (TNXP) stock jumped 11% Friday after the company issued a business update along with a preliminary 2024 ...

Tonix shares are moving higher on Friday after the company provided preliminary 2024 fiscal-year financial results.

Tonix Pharmaceuticals (TNXP) announced that it will effect a 1-for-100 reverse stock split of its outstanding common stock. The reverse stock ...